Form 4: Agenus Inc. Executive Receives Stock Options as Retention Award

Christine Klaskin, PFO & PAO of Agenus Inc., was granted 10,000 stock options as a one-time retention award.

Summary

• Christine Klaskin, the Principal Financial Officer and Principal Accounting Officer of Agenus Inc., received 10,000 stock options on November 14, 2024.
• These options were granted as a one-time retention award to key employees, including executive officers.
• The options have an exercise price of $2.77 per share and will vest on November 15, 2025.
• The options expire on November 14, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating a positive but not extraordinary event. The retention award suggests confidence in the employee's value to the company.

Positives

• The granting of stock options can serve as an incentive for key employees to remain with the company.
• The vesting period of the options aligns employee interests with the long-term performance of the company.

Risks

• The value of the stock options is dependent on the future performance of Agenus Inc.'s stock price.
• If the stock price does not increase above the exercise price, the options may not be valuable to the recipient.

Future Outlook

The stock options will vest on November 15, 2025, contingent on the employee's continued service with the company.

Management Comments

• The stock options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.

Industry Context

Granting stock options is a common practice in the biotechnology industry to attract and retain key talent, aligning their interests with the company's long-term success.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in the biotech industry, similar to companies like Gilead Sciences and Regeneron Pharmaceuticals.
• The vesting period of one year is relatively standard, although some companies may have longer or shorter vesting periods.
• The exercise price of $2.77 is specific to Agenus Inc.'s stock price at the time of the grant.

Stakeholder Impact

• The stock option grant may positively impact employee morale and retention.
• Shareholders may view this as a positive sign of management's commitment to the company's long-term success.

Key Dates

Keywords

stock options, retention award, executive compensation, Agenus Inc., equity incentive plan, Christine Klaskin